James T Dalton - Net Worth and Insider Trading
James T Dalton Net Worth
The estimated net worth of James T Dalton is at least $0 dollars as of 2024-09-20. James T Dalton is the VP, Chief Scientific Officer of Oncternal Therapeutics Inc and owns about 0 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $0. Details can be seen in James T Dalton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James T Dalton has not made any transactions after 2014-06-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James T Dalton
James T Dalton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James T Dalton owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of James T Dalton’s form 4 insider trades.
Insider Ownership Summary of James T Dalton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2014-06-06 | VP & Chief Scientific Officer |
James T Dalton Latest Holdings Summary
James T Dalton currently owns a total of 1 stock. James T Dalton owns 0 shares of Oncternal Therapeutics Inc (ONCT) as of June 6, 2014, with a value of $0.
Latest Holdings of James T Dalton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2014-06-06 | 0 | 1.59 | 0 |
Holding Weightings of James T Dalton
James T Dalton Form 4 Trading Tracker
According to the SEC Form 4 filings, James T Dalton has made a total of 0 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years. The most-recent trade in Oncternal Therapeutics Inc is the sale of 52 shares on June 6, 2014, which brought James T Dalton around $94,748.
Insider Trading History of James T Dalton
- 1
James T Dalton Trading Performance
James T Dalton Ownership Network
James T Dalton Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
James T Dalton is the VP & Chief Scientific Officer of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, James T Dalton made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 150,000 shares made by James B Breitmeyer , and a net purchase of 30,000 shares made by Richard G Vincent .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 23,880 shares were bought by its insiders, resulting in a net purchase of 22,900 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
James T Dalton Mailing Address
Above is the net worth, insider trading, and ownership report for James T Dalton. You might contact James T Dalton via mailing address: 175 Toyota Plaza, 7th Floor, Memphis Tn 38103.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
